Tag Archives: NK/Ly tumor cells

Bioenergetic characteristics of the murine Nemeth-Kellner lymphoma cells exposed to thiazole derivative in complex with polymeric nanoparticles

M. V. Ilkiv1, Ya. R. Shalai1, H. M. Mazur1, B. O. Manko1,
B. V. Manko1, Yu. V. Ostapiuk2, N. E. Mitina3,
A. S. Zaichenko3, A. M. Babsky1

1Biology Faculty, Ivan Franko National University of Lviv, Ukraine;
2Chemistry Faculty, Ivan Franko National University of Lviv, Ukraine;
3Institute of Chemistry and Chemical Technologies,
Lviv Polytechnic National University, Ukraine;
e-mail: popovych.marta@gmail.com

Received: 27 September 2022; Revised: 01 December 2022;
Accepted: 17 February 2023; Available on-line: 27 February 2023

The development of a new anticancer drugs targeted at energy metabolism of tumor cells is a promising­ approach for cancer treatment. The aim of our study was to investigate the action of thiazole derivative N-(5-benzyl-1,3-thiazol-2-yl)-3,5-dimethyl-1-benzofuran-2-carboxamide (BF1) and its complex with PEG based polymeric nanoparticle (PEG-PN) on respiration and mitochondrial membrane potential in murine NK/Ly tumor cells. The rate of oxygen uptake in NK/Ly cells was recorded by a polarographic method using a Clark electrode. The mitochondrial potential relative values were registered using fluorescence TMRM dye. No changes in glucose-fuelled basal respiration or maximal FCCP-stimulated respiration was detected after 15-min incubation of cells with BF1 (10 µM), PEG-PN or BF1 + PEG-PN complex Fluorescent microscopy data showed that BF1 or PEG-PN separately had no effect on the value of mitochondrial membrane potential, while BF1 + PEG-PN complex caused a significant decrease in mitochondrial membrane potential, indicating­ on the decrease of NK/Ly cells viability.